2010 Portfolio News
News from the portfolios of HBM BioVentures and HBM BioCapital
HBM Partners to launch new M&A Report at BioBusiness Network conference (29-30 September 2010, Geneva) (42 KB)30.06.2010
- Anthera enrolls first patients in pivotal Varespladib phase 3 clinical study (18 KB)
23.06.2010
- PTC Therapeutics awarded $5.4 million grant from the Wellcome Trust (9 KB)
07.06.2010
- Nabriva initiates phase II of pleuromutilin antibiotic BC-3781 (31 KB)
02.06.2010
- Mpex Pharmaceuticals presents positive phase 2 clinical trial results of Aeroquin (MP-376) treatment in Cystic Fibrosis patients (126 KB)
17.05.2010
- FDA Advisory Committee to review Lux Biosciences' Uveitis candidate Luveniq (22 KB)
11.05.2010
- Asthmatx receives FDA approval for the Alair Bronchial Thermoplasty System (66 KB)
27.04.2010
- Interventional Spine announces first US implant of RENEW for lumbar spinal stenosis (91 KB)
19.04.2010
- Lux Biosciences' Luveniq receives FDA priority review (24 KB)
30.03.2010
- Lux Biosciences' Luveniq receives FDA priority review (22 KB)
30.03.2010
- Anthera Pharmaceuticals completes Initial Public Offering (16 KB)
04.03.2010
- Abbott and Enanta announce advancement of Hepatitis C collaboration (27 KB)
02.03.2010
News
M&A Report
Links
Subscribe To Our Newsletter
Search
© HBM Partners AG 18.05.2012